The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 1,385 | 6,921 | SH | SOLE | NONE | 6,921 | 0 | 0 | |
| BAXTER INTL INC | COM | 071813109 | 9,104 | 169,028 | SH | SOLE | NONE | 169,028 | 0 | 0 | |
| BIOGEN INC | COM | 09062X103 | 29,431 | 110,230 | SH | SOLE | NONE | 110,230 | 0 | 0 | |
| BIO RAD LABS INC | CL A | 090572207 | 5,001 | 11,988 | SH | SOLE | NONE | 11,988 | 0 | 0 | |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 9,291 | 109,604 | SH | SOLE | NONE | 109,604 | 0 | 0 | |
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 25,139 | 353,627 | SH | SOLE | NONE | 353,627 | 0 | 0 | |
| BRUKER CORP | COM | 116794108 | 12,626 | 237,958 | SH | SOLE | NONE | 237,958 | 0 | 0 | |
| BOSTON SCIENTIFIC CORP | COM | 101137107 | 14,996 | 387,184 | SH | SOLE | NONE | 387,184 | 0 | 0 | |
| CARDINAL HEALTH INC | COM | 14149Y108 | 23,918 | 358,700 | SH | SOLE | NONE | 358,700 | 0 | 0 | |
| CIGNA CORP NEW | COM | 125523100 | 14,017 | 50,517 | SH | SOLE | NONE | 50,517 | 0 | 0 | |
| CENTENE CORP DEL | COM | 15135B101 | 15,683 | 201,555 | SH | SOLE | NONE | 201,555 | 0 | 0 | |
| CVS HEALTH CORP | COM | 126650100 | 4,143 | 43,443 | SH | SOLE | NONE | 43,443 | 0 | 0 | |
| ELEVANCE HEALTH INC | COM | 036752103 | 20,910 | 46,032 | SH | SOLE | NONE | 46,032 | 0 | 0 | |
| EMBECTA CORP | COMMON STOCK | 29082K105 | 151 | 5,246 | SH | SOLE | NONE | 5,246 | 0 | 0 | |
| GILEAD SCIENCES INC | COM | 375558103 | 54,479 | 883,106 | SH | SOLE | NONE | 883,106 | 0 | 0 | |
| INCYTE CORP | COM | 45337C102 | 27,908 | 418,794 | SH | SOLE | NONE | 418,794 | 0 | 0 | |
| IONIS PHARMACEUTICALS INC | COM | 462222100 | 7,264 | 164,223 | SH | SOLE | NONE | 164,223 | 0 | 0 | |
| INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 3,193 | 68,612 | SH | SOLE | NONE | 68,612 | 0 | 0 | |
| MEDTRONIC PLC | SHS | G5960L103 | 21,799 | 269,957 | SH | SOLE | NONE | 269,957 | 0 | 0 | |
| MERCK & CO INC | COM | 58933Y105 | 21,802 | 253,159 | SH | SOLE | NONE | 253,159 | 0 | 0 | |
| NUVASIVE INC | COM | 670704105 | 10,893 | 248,649 | SH | SOLE | NONE | 248,649 | 0 | 0 | |
| NOVAVAX INC | COM NEW | 670002401 | 1,033 | 56,735 | SH | SOLE | NONE | 56,735 | 0 | 0 | |
| PTC THERAPEUTICS INC | COM | 69366J200 | 4,352 | 86,692 | SH | SOLE | NONE | 86,692 | 0 | 0 | |
| QIAGEN NV | SHS NEW | N72482123 | 8,424 | 204,074 | SH | SOLE | NONE | 204,074 | 0 | 0 | |
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 1,885 | 45,520 | SH | SOLE | NONE | 45,520 | 0 | 0 | |
| RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 1,589 | 1,346,904 | SH | SOLE | NONE | 1,346,904 | 0 | 0 | |
| SAGE THERAPEUTICS INC | COM | 78667J108 | 4,531 | 115,696 | SH | SOLE | NONE | 115,696 | 0 | 0 | |
| SEAGEN INC | COM | 81181C104 | 11,594 | 84,730 | SH | SOLE | NONE | 84,730 | 0 | 0 | |
| UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 2,388 | 27,077 | SH | SOLE | NONE | 27,077 | 0 | 0 | |
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | 1,731 | 89,808 | SH | SOLE | NONE | 89,808 | 0 | 0 | |
| ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | 17,364 | 166,080 | SH | SOLE | NONE | 166,080 | 0 | 0 | |